On cue, MF issues a positive report. There must be an AGM,...

On cue, MF issues a positive report. There must be an AGM, results or something fundamental in the wind for someone to have given a taste to MF:
"Sirtex has developed a product that helps people with liver cancer, Sir-Spheres. The company continues to report growing sales, despite reaching 2% of its addressable market so far. In 2016, dose sales grew 16.7%, and the company has forecast another year of double-digit unit sales growth in FY17. The share price is trading below $30, which represents a P/E ratio of around 31x. For a company of Sirtex’s quality and potential, that appears cheap."
www.**promotion blocked**.au/2016/10/23/3-high-quality-stocks-id-buy-with-10000-today/